Suggested Topics within your search.
Showing 241 - 260 results of 328 for search '"Health Economics"', query time: 0.07s Refine Results
  1. 241
    Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary

    Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary by Raymond Odhiambo, Jagpreet Chhatwal, Shannon Allen Ferrante, Antoine El Khoury, Elamin Elbasha

    Published 2013-06-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 242
    Secondary Prevention Using Cholesterol-Lowering Medications in Patients with Prior Atherosclerotic Cardiovascular Disease Events: A Retrospective Cohort Analysis

    Secondary Prevention Using Cholesterol-Lowering Medications in Patients with Prior Atherosclerotic Cardiovascular Disease Events: A Retrospective Cohort Analysis by Xue Han, Steven Fox, Michelle Chu, Jeff McCombs

    Published 2022-01-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 243
    Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database

    Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database by Ariel Berger, John Edelsberg, Simon Teal, Marko A. Mychaskiw, Gerry Oster

    Published 2014-02-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 244
    Surgical Treatment Patterns, Healthcare Resource Utilization, and Economic Burden in Patients with Tenosynovial Giant Cell Tumor Who Underwent Joint Surgery in the United States

    Surgical Treatment Patterns, Healthcare Resource Utilization, and Economic Burden in Patients with Tenosynovial Giant Cell Tumor Who Underwent Joint Surgery in the United States by Feng Lin, Winghan J. Kwong, Sherry Shi, Irina Pivneva, Eric Q. Wu, John A. Abraham

    Published 2022-03-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 245
    Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece

    Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece by George Gourzoulidis, Oresteia Zisimopoulou, Nadia Boubouchairopoulou, Christina Michailidi, Chrissy Lowry, Charalampos Tzanetakos, Georgia Kourlaba

    Published 2022-02-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 246
    Drug Insurance and Psoriasis Severity: A Retrospective Cohort Study

    Drug Insurance and Psoriasis Severity: A Retrospective Cohort Study by Laurence Mainville, Hélène Veillette, Paul R. Fortin

    Published 2025-02-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 247
    The Direct Healthcare Expenditures of Prostate Cancer by Disease Severity: Evidence from US National Survey Data

    The Direct Healthcare Expenditures of Prostate Cancer by Disease Severity: Evidence from US National Survey Data by Peter J. Mallow, Jie Chen, John A. Rizzo, John R. Penrod, Geralyn C. Trudel, Teresa M. Zyczynski

    Published 2016-10-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 248
    Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm

    Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based... by Scott Goulden, Qin Shen, Robert L. Coleman, Cara Mathews, Matthias Hunger, Ankit Pahwa, Rene Schade

    Published 2023-09-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 249
    Clinical and Economic Outcomes Associated With Use of Liposomal Bupivacaine Versus Standard of Care for Management of Postsurgical Pain in Pediatric Patients Undergoing Spine Surgery

    Clinical and Economic Outcomes Associated With Use of Liposomal Bupivacaine Versus Standard of Care for Management of Postsurgical Pain in Pediatric Patients Undergoing Spine Surge... by Robert Tracy Ballock, John Seif, Ryan Goodwin, Jennifer H. Lin, Jessica Cirillo

    Published 2021-04-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 250
    No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients

    No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients by Bruce S. Pyenson, Carol M. Bazell, Michael J. Bellanich, Melissa A. Caplen, Javier J. Zulueta

    Published 2019-05-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 251
    Relationship Between the Number of Occlusal Supporting and Medical Cost: Analysis Using Large Claims Database from Employee Health Care Insurance in Japan

    Relationship Between the Number of Occlusal Supporting and Medical Cost: Analysis Using Large Claims Database from Employee Health Care Insurance in Japan by Tatsunori Murata, Korenori Arai, Kosuke Kashiwagi, Shunsuke Baba

    Published 2020-01-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 252
    Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors

    Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors by Yen-Wen Chen, Helene Hardy, Christopher D. Pericone, Wing Chow

    Published 2020-07-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 253
    Assessing the Fiscal Burden of Overweight and Obesity in Japan through Application of a Public Economic Framework

    Assessing the Fiscal Burden of Overweight and Obesity in Japan through Application of a Public Economic Framework by Ataru Igarashi, Cillian Copeland, Nikos Kotsopoulos, Riku Ota, Silvia Capucci, Daisuke Adachi

    Published 2024-11-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 254
    An Insurance Value Modeling Approach That Captures the Wider Value of a Novel Antimicrobial to Health Systems, Patients, and the Population

    An Insurance Value Modeling Approach That Captures the Wider Value of a Novel Antimicrobial to Health Systems, Patients, and the Population by Mei S. Chan, Richard Holloway, Robert King, Rosie Polya, Rebecca Sloan, Jack C. Kowalik, Tom Ashfield, Luke S.P. Moore, Thomas Porter, Jonathan Pearson-Stuttard

    Published 2023-07-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 255
    Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation

    Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation by Derralynn Hughes, Andrew Lenny, Koonal Shah, Louise Longworth, Giovanna Devercelli, Olulade Ayodele

    Published 2023-04-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 256
    Effectiveness of a Patient Support Program in Supporting Access to Therapy for Solid Tumor Malignancies

    Effectiveness of a Patient Support Program in Supporting Access to Therapy for Solid Tumor Malignancies by Lindsay Parker, Alissa Shaul, Brian Murphy, Zeba M. Khan

    Published 2016-10-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 257
    Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey

    Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey by Ilhan Satman, Hayley Bennett, Candeger Yilmaz, Sazi Imamoglu, Goksun Ayvaz, Abdurrahman Comlekci, Demet Ozkaya, Toros Sahin

    Published 2013-08-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 258
    Dissemination of Evidence-Based Recommendations for Sickle Cell Disease to Primary Care and Emergency Department Providers in North Carolina: A Cost Benefit Analysis

    Dissemination of Evidence-Based Recommendations for Sickle Cell Disease to Primary Care and Emergency Department Providers in North Carolina: A Cost Benefit Analysis by Paula Tanabe, Audrey L. Blewer, Emily Bonnabeau, Hayden B. Bosworth, Denise H. Clayton, Nancy Crego, Marian F. Earls, Kern Eason, Grayson Forlines, Gary Rains, Matthew Young, Nirmish Shah

    Published 2021-04-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 259
    Health Care Costs attributable to Hospital-diagnosed Back Pain: A Longitudinal Register-based Study of the Danish Population

    Health Care Costs attributable to Hospital-diagnosed Back Pain: A Longitudinal Register-based Study of the Danish Population by Rikke Søgaard, Jan Sørensen

    Published 2014-02-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 260
    Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria

    Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria by Yazid Aoudia, Thitima Kongnakorn, Evie Merinopoulou, Mohamed Said Bettayeb, Sid Ahmed Kherraf

    Published 2017-05-01
    “…Journal of Health Economics and Outcomes Research…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: